OTCQB Listing Requirements

Where OTCQB sits in the OTC tier structure

OTC Markets Group operates three marketplaces, ranked by disclosure and financial standard: OTC Pink (no minimum financial standard, self-certified disclosure), OTCQB (the venture-stage tier, built for early and developing companies that are already SEC-reporting), and OTCQX (the top tier, requiring profitability or asset tests, a $10M market cap floor, and no cure period leniency). OTCQB is the practical landing tier for a company that has just completed an S-1, Reg A+ offering, or reverse merger and needs a public quotation without the cost and diligence load of a national exchange listing. It is not a stepping stone through OTC Pink — a company can go straight from private, or from an S-1 effective date, to an OTCQB application, provided it clears the standards below.

Eligibility standards

OTCQB eligibility is a checklist, not a scored test — miss any one item and the application stalls or the company is later removed. The current standards, read from the OTCQB Rules:

Minimum bid price — verify before you rely on any guide, including this one. The current OTCQB Rules (V6, effective 2026-04-06) set a $0.05 minimum closing bid price for 30 consecutive calendar days immediately before admission. A large share of the guides ranking for "OTCQB listing requirements" — including securitieslawyer101 and legalandcompliance — still cite the older $0.01 threshold. That figure was accurate under a prior rules version; it is not the number OTC Markets applies today. Confirm the live figure directly against the current OTCQB Rules PDF at otcmarkets.com before pricing a reverse split or bridge round around it.

• Beneficial holders: at least 50 beneficial shareholders, each holding 100 or more shares (round lot holders). This is the single most common blocker for companies converting from a small Reg A+ or Reg D raise — a tight, insider-heavy cap table often can't clear 50 holders without a secondary distribution.
• Public float: freely tradable shares equal to at least 10% of shares outstanding, held by non-affiliates. Shares subject to Rule 144 restriction, lockups, or held by officers, directors, and 10%+ owners don't count toward this float.
• Audit: annual financial statements audited by a PCAOB-registered auditor, prepared under US GAAP — unless the company is already a fully reporting SEC filer whose audited financials satisfy this independently.
• Reporting status: the company must be current in SEC reporting (Exchange Act 1934 reporting) or Regulation A reporting, or qualify as a foreign private issuer exempt under Rule 12g3-2(b) with a listing on a qualified foreign exchange. Stale or delinquent filings are an immediate disqualifier, not a curable deficiency.
• No shell companies: OTCQB explicitly prohibits shell companies — entities with no or nominal operations and no or nominal assets other than cash. A reverse-merger target must have completed its "super 8-K" and be operating the acquired business before it can apply.
• Transfer agent participation: the company's transfer agent must participate in OTC Markets' Transfer Agent Verified Shares Program (TAVS), which reconciles the transfer agent's share count against the company's disclosed share structure.
• Verified Profile and annual certification: the company must complete and maintain a Verified Company Profile on otcmarkets.com and have an officer certify annually that it continues to meet all OTCQB standards. This certification — not just the initial application — is what keeps a ticker on OTCQB year over year.
• 90-day cure period: if the bid price falls below the $0.05 threshold after admission, OTC Markets gives the company 90 calendar days to cure before initiating removal to OTC Pink. There is no equivalent grace period for a holder-count or float shortfall — those are treated as an ongoing eligibility failure.

Application process, step by step

1. Confirm eligibility first. Run the checklist above against your actual cap table and reporting status before spending on the next steps — a holder-count or shell-status problem is expensive to discover after legal and audit work is underway.
2. Get quoted, if not already. A company with no existing public market must have a FINRA-member sponsoring broker-dealer file Form 211 under Rule 15c2-11 to initiate quotation. As of 2026-03-30, Form 211 is filed electronically through the FINRA Gateway platform; issuers cannot file it directly. This step alone commonly runs 4–8 weeks.
3. Enroll your transfer agent in TAVS. This must be in place before OTC Markets will approve the application — it's the mechanism OTC Markets uses to independently verify your share count.
4. Build the Verified Profile. Create and verify the company's profile on OTC Markets' Disclosure & News Service, including officer and director information, which OTC Markets checks against its background-check standards.
5. Submit the OTCQB application through the otcmarkets.com portal with the application fee, current audited financials, and the standards certification.
6. OTC Markets review. Typically a matter of weeks once the file is complete; incomplete filings (missing audit opinion, unresolved 12g3-2(b) status, TAVS not yet active) are the most common cause of delay, not a substantive standards dispute.
7. Approval and quotation begins on the OTCQB tier under the existing or newly assigned ticker.
8. Ongoing compliance: pay the annual fee, keep SEC/Reg A reporting current, and complete the annual standards certification — this is a recurring obligation, not a one-time gate.

OTCQB vs. OTCQX — standards and fees, read live from the same source every calculator on this site uses

OTC Pink sits below both: no minimum bid, holder count, or float test, and no audit requirement — disclosure can be as light as "limited" or "no information," which is why it isn't included in the table above as a standards comparison. Positioning between the three tiers is a disclosure-and-diligence decision as much as an eligibility one: OTCQB is the tier where a real audit and real reporting first become mandatory, which is what most institutional-adjacent investors and market makers treat as the practical floor for taking a name seriously.

Common deficiencies that stall or sink an application

• Bid price not sustained for the full 30 days. A single day's closing print below the threshold resets the clock — thin, illiquid pre-admission trading is the most common cause.
• Under 50 beneficial holders. Founder-heavy cap tables from a small Reg D or Reg A+ raise routinely fall short; a secondary distribution or broader placement is often needed before applying.
• Float under 10%. Even with enough holders, if too much of the float sits with affiliates or under lockup, the float test fails independently of the holder count.
• Delinquent SEC or Reg A reporting. A late 10-K or 10-Q — even one still within a Rule 12b-25 extension — can hold up review until the company is current.
• Transfer agent not yet enrolled in TAVS. This is a paperwork lag, not a standards problem, but it's a frequent last-mile delay because it depends on the transfer agent's own onboarding timeline, not the issuer's.
• Shell classification. A reverse-merger shell that hasn't yet closed and disclosed its operating acquisition (via the Super 8-K) will be rejected outright, regardless of how the other standards look.
• Lapsed annual certification. Existing OTCQB companies get removed for failing to complete the annual standards certification, not just for a bid-price or float shortfall — treat it as a compliance deadline, not a formality.

The uplisting path from here

OTCQB is a venture-stage tier by design — it's not meant to be a permanent home for a company that's outgrown it. The two directions from OTCQB are uplisting to OTCQX (a disclosure and profitability step, not a new exchange) or uplisting to a national exchange like Nasdaq Capital Market, which requires clearing a materially higher stockholders'-equity, market-value, and round-lot-holder bar under Nasdaq Rule 5505. Run the Uplisting Checker against your current cap table and financials to see which gap is largest, and read the Nasdaq Listing Requirements guide before assuming a reverse split alone clears the bar — Nasdaq's 2026 guidance flags that rounding up fractional holders in a split doesn't automatically cure the 300 round-lot-holder requirement.